Immunotherapy and Radiation: Charting a Path Forward Together.

Link to article at PubMed

Icon for Elsevier Science Related Articles

Immunotherapy and Radiation: Charting a Path Forward Together.

Hematol Oncol Clin North Am. 2019 Dec;33(6):1057-1069

Authors: Sridharan V, Schoenfeld JD

Preclinical studies combining immunotherapy and radiation therapy have suggested promising synergy, prompting translation into clinical trials. Radiation has been shown to significantly alter the tumor microenvironment, cause immunogenic cell death, and potentiate anti-tumor immune responses. Several radiation parameters may modulate these effects. Clinical data to date have suggested that combination therapy is largely well tolerated, but additional study is warranted to better estimate both short-term and long-term risks of combination treatment and extend these data to new immunotherapy agents. Ensuring proper radiation access and quality is critical to the success of future trials.

PMID: 31668206 [PubMed - in process]

Leave a Reply

Your email address will not be published.